Clinical features of idiopathic restrictive cardiomyopathy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hong, Jung Ae | - |
dc.contributor.author | Kim, Min-Seok | - |
dc.contributor.author | Cho, Min-Su | - |
dc.contributor.author | Choi, Hyo In | - |
dc.contributor.author | Kang, Duk-Hyun | - |
dc.contributor.author | Lee, Sang-Eun | - |
dc.contributor.author | Lee, Ga-Yeon | - |
dc.contributor.author | Jeon, Eun-Seok | - |
dc.contributor.author | Cho, Jae-Yeong | - |
dc.contributor.author | Kim, Kye-Hun | - |
dc.contributor.author | Yoo, Byung-Su | - |
dc.contributor.author | Lee, Jong-Young | - |
dc.contributor.author | Kim, Won-Jang | - |
dc.contributor.author | Kim, Kyung-Hee | - |
dc.contributor.author | Chung, Wook-Jin | - |
dc.contributor.author | Lee, Ju-Hee | - |
dc.contributor.author | Cho, Myeong-Chan | - |
dc.contributor.author | Kim, Jae-Joong | - |
dc.date.available | 2020-02-27T17:42:54Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 0025-7974 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5773 | - |
dc.description.abstract | Idiopathic restrictive cardiomyopathy (RCMP) has not been fully understood because this disease is difficult to diagnose. The present study aimed to assess the clinical profile and outcome of idiopathic RCMP from a multicenter cohort. This investigation is a retrospective study of consecutive patients with idiopathic RCMP at 10 centers in Korea between 1990 and 2010. We evaluated the clinical characteristics of the patients and prognostic factors associated with mortality using multivariate Cox proportional hazards regression analyses. The study included 53 patients (26 men, 49.1%). During a median follow-up of 1.7 years, 17 patients (32.1%) died and 5 patients (9.4%) received a heart transplant. The 5-year survival rate of the overall patients was 64.4%+/- 7.8%. In multivariable analyses, the predictors of mortality were tricuspid regurgitation (TR)>= moderate (hazard ratio [HR] 32.55, P <.001) and left ventricular end-diastolic diameter (LVEDD) (HR 0.85, P <.001). Idiopathic RCMP showed unfavorable prognosis. Advanced TR and lower LVEDD are independent adverse predictors of mortality in patients with idiopathic RCMP. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.relation.isPartOf | MEDICINE | - |
dc.subject | HEART-FAILURE | - |
dc.subject | CLASSIFICATION | - |
dc.subject | DISEASE | - |
dc.title | Clinical features of idiopathic restrictive cardiomyopathy | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000409904600022 | - |
dc.identifier.doi | 10.1097/MD.0000000000007886 | - |
dc.identifier.bibliographicCitation | MEDICINE, v.96, no.36 | - |
dc.identifier.scopusid | 2-s2.0-85028996065 | - |
dc.citation.title | MEDICINE | - |
dc.citation.volume | 96 | - |
dc.citation.number | 36 | - |
dc.contributor.affiliatedAuthor | Chung, Wook-Jin | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | idiopathic restrictive cardiomyopathy | - |
dc.subject.keywordAuthor | outcome | - |
dc.subject.keywordAuthor | risk factor | - |
dc.subject.keywordPlus | HEART-FAILURE | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | DISEASE | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.